Latest news
Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress - BioSpaceBioSpace · Fri, 07 Aug 2026 10:26:31 GMTWave Life Sciences Reports Q2 2026 Results, Dosing Underway in Phase 2a INLIGHT Trial of WVE-007 and Advances RNA Editing Pipeline - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 11:44:00 GMTWVE: Strong clinical progress in RNAi/editing pipeline, robust cash runway, and key trials advancing - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTPYC Therapeutics Advances RNA Pipeline With PKD Phase 1b Dosing Escalation and Orphan Drug Designation for RP11 - KalkineKalkine · Wed, 29 Jul 2026 07:00:00 GMTRactigen Therapeutics Closes Over $31 Million Financing to Advance Clinical-Stage saRNA Pipeline and Proprietary Extrahepatic Delivery Platforms - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 07:00:00 GMT